This partnership renewal underscores DKSH's commitment to delivering exceptional healthcare solutions and mutual success in the pharmaceutical industry.

Since its inception in 2017, the collaboration between DKSH and Church & Dwight has flourished, with DKSH providing full agency services for Church & Dwight's pharmaceutical product, Anusol. Through targeted marketing strategies and a profound understanding of patient needs, Anusol has emerged as the leading anti-hemorrhoidal brand in Hong Kong, widely accessible in hospitals, clinics, pharmacies, and key chain stores.

The contract signing ceremony, held at the DKSH office in Hong Kong, marked a significant milestone in this strategic partnership. Attended by key representatives from both DKSH and Church & Dwight, the event symbolized their shared vision and determination to achieve remarkable success and continued growth.

"We are thrilled to extend our partnership with DKSH Business Unit Healthcare as we continue our journey of providing exceptional healthcare solutions to the Hong Kong market. DKSH's extensive network has been instrumental in elevating our pharmaceutical product to new heights. Together with DKSH Business Unit Healthcare, we are excited about the opportunities that lie ahead," stated Mr. Arun Hiranandani, Vice President, Global Market Group at Church & Dwight.

"We are honored to have been Church & Dwight's trusted partner since 2017. Through our expertise, we managed to strategically unlock the brand's potential, resulting in exceptional growth across Hong Kong. This collaboration showcases our dedication to providing 'Healthcare for All', and we eagerly anticipate reaching new milestones together," said Wai Ting Fong, Head of Management and Vice President, Healthcare Hong Kong & Macau at DKSH.

As a trusted partner, DKSH remains committed to delivering service excellence and prioritizing accessible healthcare for all. This partnership exemplifies DKSH's dedication to creating a healthcare landscape where individuals from diverse backgrounds can readily access solutions to improve patient outcomes.